 <h1>Heplisav-B Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>hepatitis b adult vaccine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about hepatitis b adult vaccine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Heplisav-B.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to hepatitis b adult vaccine: intramuscular solution</i></p><p>Other dosage forms:</p><ul><li>intramuscular suspension</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, hepatitis b adult vaccine (the active ingredient contained in Heplisav-B) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking hepatitis b adult vaccine:</p><p>
<i>Rare</i>
</p><ul>
<li>Chest pain or discomfort</li>
<li>inability to move the arms and legs</li>
<li>nausea</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>sudden numbness and weakness in the arms and legs</li>
<li>sweating</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of hepatitis b adult vaccine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>General feeling of discomfort or illness</li>
<li>headache</li>
<li>pain at the injection site</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Fever</li>
<li>redness or swelling at the injection site</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to hepatitis b adult vaccine: intramuscular solution, intramuscular suspension</i></p><h3>General</h3><p>The most common adverse events were injection site reactions, headache, and fatigue.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site pain (33.8%), injection site soreness (22%), injection site redness (15.6%), injection site swelling (11.7%)</p>
<p><b>Common</b> (1% to 10%): Injection site induration</p>
<p><b>Uncommon</b> (0.1% to 1%): Injection site ecchymosis, injection site pruritus</p>
<p><b>Postmarketing reports</b>: Injection site reaction<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (23.4%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, drowsiness</p>
<p><b>Uncommon</b> (0.1% to 1%): Somnolence, tingling, paresthesia</p>
<p><b>Postmarketing reports</b>: Encephalitis, encephalopathy, migraine, multiple sclerosis, neuritis, neuropathy including hypoesthesia, Guillain-Barre syndrome and Bell's palsy, optic neuritis, paralysis, paresis, seizures, syncope, transverse myelitis, vertigo, demyelinating disease of the central nervous system, exacerbation of multiple sclerosis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (33.8%)</p>
<p><b>Common</b> (1% to 10%): Fever, malaise</p>
<p><b>Uncommon</b> (0.1% to 1%): Chills, influenza-like symptoms, sweating, achiness, sensation of warmth, lightheadedness, flushing, earache</p>
<p><b>Postmarketing reports</b>: Tinnitus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Apparent hypersensitivity syndrome (serum sickness-like) of delayed onset has been reported days to weeks after vaccination, including: arthralgia/arthritis (usually transient), fever, and dermatologic reactions such as urticaria, erythema multiforme, ecchymosis, and erythema nodosum.<sup>[Ref]</sup></p><p><b>Postmarketing reports</b>: Allergic reaction, anaphylactoid reaction, anaphylaxis, apparent hypersensitivity syndrome<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Appetite lost</p>
<p><b>Uncommon</b> (0.1% to 1%): Anorexia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Irritability</p>
<p><b>Uncommon</b> (0.1% to 1%): Agitation, insomnia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngitis, upper respiratory infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Upper respiratory tract illnesses, rhinitis, cough, influenza</p>
<p><b>Frequency not reported</b>: Pharyngitis</p>
<p><b>Postmarketing reports</b>: Apnea, bronchospasm including asthma-like symptoms<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Arthralgia, back pain, myalgia, pain/stiffness in arm, shoulder, or neck</p>
<p><b>Postmarketing reports</b>: Arthritis, muscular weakness<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Gastrointestinal symptoms</p>
<p><b>Uncommon</b> (0.1% to 1%): Abdominal pain/cramps, constipation, diarrhea, nausea, vomiting</p>
<p><b>Postmarketing reports</b>: Dyspepsia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Lymphadenopathy</p>
<p><b>Postmarketing reports</b>: Thrombocytopenia, increased erythrocyte sedimentation rate<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Erythema, petechiae, pruritus, rash, sweating, urticaria</p>
<p><b>Postmarketing reports</b>: Alopecia, angioedema, eczema, erythema multiforme including Stevens-Johnson syndrome, erythema nodosum, lichen planus, purpura<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Flushing, hypotension</p>
<p><b>Postmarketing reports</b>: Palpitations, tachycardia, vasculitis, syncope<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very rare</b> (less than 0.01%): Uveitis</p>
<p><b>Postmarketing reports</b>: Conjunctivitis, keratitis, visual disturbances, optic neuritis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Dysuria<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Abnormal liver function tests<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Postmarketing reports</b>: Herpes zoster, meningitis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Engerix-B (hepatitis B vaccine)." SmithKline Beecham, Philadelphia, PA. </p><p id="ref_3">3. "Product Information. Recombivax HB (hepatitis B vaccine)." Merck &amp; Company Inc, West Point, PA. </p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What is the difference between Heplisav-B and Engerix-B?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Heplisav-B (hepatitis b adult vaccine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Heplisav-B &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Engerix-B, Recombivax HB Adult, Recombivax HB Dialysis Formulation</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Hepatitis B Prevention</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to hepatitis b adult vaccine: intramuscular solution, intramuscular suspension</i></p><h3>General</h3><p>The most common adverse events were injection site reactions, headache, and fatigue.<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site pain (33.8%), injection site soreness (22%), injection site redness (15.6%), injection site swelling (11.7%)</p><p><b>Common</b> (1% to 10%): Injection site induration</p><p><b>Uncommon</b> (0.1% to 1%): Injection site ecchymosis, injection site pruritus</p><p><b>Postmarketing reports</b>: Injection site reaction<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (23.4%)</p><p><b>Common</b> (1% to 10%): Dizziness, drowsiness</p><p><b>Uncommon</b> (0.1% to 1%): Somnolence, tingling, paresthesia</p><p><b>Postmarketing reports</b>: Encephalitis, encephalopathy, migraine, multiple sclerosis, neuritis, neuropathy including hypoesthesia, Guillain-Barre syndrome and Bell's palsy, optic neuritis, paralysis, paresis, seizures, syncope, transverse myelitis, vertigo, demyelinating disease of the central nervous system, exacerbation of multiple sclerosis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (33.8%)</p><p><b>Common</b> (1% to 10%): Fever, malaise</p><p><b>Uncommon</b> (0.1% to 1%): Chills, influenza-like symptoms, sweating, achiness, sensation of warmth, lightheadedness, flushing, earache</p><p><b>Postmarketing reports</b>: Tinnitus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Apparent hypersensitivity syndrome (serum sickness-like) of delayed onset has been reported days to weeks after vaccination, including: arthralgia/arthritis (usually transient), fever, and dermatologic reactions such as urticaria, erythema multiforme, ecchymosis, and erythema nodosum.<sup>[Ref]</sup></p><p><b>Postmarketing reports</b>: Allergic reaction, anaphylactoid reaction, anaphylaxis, apparent hypersensitivity syndrome<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Appetite lost</p><p><b>Uncommon</b> (0.1% to 1%): Anorexia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Irritability</p><p><b>Uncommon</b> (0.1% to 1%): Agitation, insomnia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngitis, upper respiratory infection</p><p><b>Uncommon</b> (0.1% to 1%): Upper respiratory tract illnesses, rhinitis, cough, influenza</p><p><b>Frequency not reported</b>: Pharyngitis</p><p><b>Postmarketing reports</b>: Apnea, bronchospasm including asthma-like symptoms<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Arthralgia, back pain, myalgia, pain/stiffness in arm, shoulder, or neck</p><p><b>Postmarketing reports</b>: Arthritis, muscular weakness<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Gastrointestinal symptoms</p><p><b>Uncommon</b> (0.1% to 1%): Abdominal pain/cramps, constipation, diarrhea, nausea, vomiting</p><p><b>Postmarketing reports</b>: Dyspepsia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Lymphadenopathy</p><p><b>Postmarketing reports</b>: Thrombocytopenia, increased erythrocyte sedimentation rate<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Erythema, petechiae, pruritus, rash, sweating, urticaria</p><p><b>Postmarketing reports</b>: Alopecia, angioedema, eczema, erythema multiforme including Stevens-Johnson syndrome, erythema nodosum, lichen planus, purpura<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Flushing, hypotension</p><p><b>Postmarketing reports</b>: Palpitations, tachycardia, vasculitis, syncope<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very rare</b> (less than 0.01%): Uveitis</p><p><b>Postmarketing reports</b>: Conjunctivitis, keratitis, visual disturbances, optic neuritis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Dysuria<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Abnormal liver function tests<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Postmarketing reports</b>: Herpes zoster, meningitis<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Engerix-B (hepatitis B vaccine)." SmithKline Beecham, Philadelphia, PA. </p><p id="ref_3">3. "Product Information. Recombivax HB (hepatitis B vaccine)." Merck &amp; Company Inc, West Point, PA. </p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is the difference between Heplisav-B and Engerix-B?</li>
</ul><h2>More about Heplisav-B (hepatitis b adult vaccine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Heplisav-B &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hepatitis B Prevention</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>